Fagområder
Vitenskapsdisipliner
Klinisk farmakologi Epidemiologi medisinsk og odontologisk statistikk Samfunnsmedisin, sosialmedisin Farmakologi
Forskningsgrupper
Publikasjoner og forskningsresultater
Vitenskapelige publikasjoner
Brenna, Ida Halvorsen;
Waleur, Karin Merethe
; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Mordal, Jon; Løberg, Else-Marie;
Weimand, Bente
;
Tanum, Lars Håkon Reiestad
(2024).
Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study.
12 s.
European Addiction Research.
https://doi.org/10.1159/000541431
Marciuch, Anne; Birkeland, Bente; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby;
Tanum, Lars Håkon Reiestad
; Mathisen, Ida;
Weimand, Bente
(2023).
Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone.
12 s.
Heliyon.
Vol. 9.
https://doi.org/10.1016/j.heliyon.2023.e17516
Weimand, Bente Margrethe ; Karlsson, Ann Tarja; Solli, Kristin Klemmetsby; Vederhus, John-Kåre; Mordal, Jon; Digranes, Linn Camilla Wergeland; Tanum, Lars Håkon Reiestad (2023). Characteristics of opioid-dependent patients choosing antagonist treatment with extended-release naltrexone compared with patients in opioid maintenance treatment in Norway. 9 s. Heroin Addiction and Related Clinical Problems. Vol. 25.
Midgard, Håvard; Malme, Kristian Braathen; Phil, Charlotte Meinich; Berg-Pedersen, Riikka Mari;
Tanum, Lars Håkon Reiestad
; Klundby, Ingvild; Haug, Anne; Tveter, Ida Giæver; Bjørnestad, Ronny; Olsen, Inge Christoffer; Finbråten, Ane-Kristine; Dalgard, Olav
(2023).
Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial.
8 s.
Clinical Infectious Diseases.
Vol. 78.
https://doi.org/10.1093/cid/ciad711
Opheim, Arild; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Kloster, Pia Synnøve; Fadnes, Lars T.; Kunøe, Nikolaj; Gaulen, Zhanna;
Tanum, Lars Håkon Reiestad
(2023).
Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial.
9 s.
Contemporary Clinical Trials.
Vol. 135.
https://doi.org/10.1016/j.cct.2023.107360
Broekhof, Rosalie; Nordahl, Hans Morten;
Tanum, Lars Håkon Reiestad
; Selvik, Sara Germans
(2023).
Adverse childhood experiences and their association with substance use disorders in adulthood: A general population study (Young-HUNT).
8 s.
Addictive Behaviors Reports.
Vol. 17.
https://doi.org/10.1016/j.abrep.2023.100488
Karlsson, Ann Tarja; Vederhus, John-Kåre; Clausen, Thomas;
Weimand, Bente Margrethe
; Solli, Kristin Klemmetsby;
Tanum, Lars Håkon Reiestad
(2022).
Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone.
7 s.
International Journal of Environmental Research and Public Health (IJERPH).
Vol. 19.
https://doi.org/10.3390/ijerph191811435
Marciuch, Anne; Brenna, Ida Halvorsen;
Weimand, Bente
; Solli, Kristin Klemmetsby;
Tanum, Lars Håkon Reiestad
; Røstad, Bente; Birkeland, Bente
(2022).
Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study.
14 s.
Addiction science & clinical practice.
Vol. 17.
https://doi.org/10.1186/s13722-022-00317-2
Brenna, Ida Halvorsen; Marciuch, Anne; Birkeland, Bente; Veseth, Marius; Røstad, Bente; Løberg, Else-Marie; Solli, Kristin Klemmetsby;
Tanum, Lars Håkon Reiestad
;
Weimand, Bente
(2021).
‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study.
Journal of Substance Abuse Treatment.
https://doi.org/10.1016/j.jsat.2021.108667
Karlsson, Ann Tarja; Vederhus, John-Kåre; Clausen, Thomas;
Weimand, Bente
; Solli, Kristin Klemmetsby;
Tanum, Lars Håkon Reiestad
(2021).
Levels of impulsivity, hyperactivity, and inattention and the association with mental health and substance use severity in opioid-dependent patients seeking treatment with extended-release naltrexone.
8 s.
Journal of Clinical Medicine.
Vol. 10.
https://doi.org/10.3390/jcm10194558